Boditech Med Inc
206640
Company Profile
Business description
Boditech Med Inc is a pharmaceutical company which provides diagnostic solutions. It develops, manufactures and distributes products for in-vitro diagnostics and diagnostic reagents. The company is also developing a smart production system that integrates digital technology and IT technology. The firm develops its products for heart disease, cancer, diabetes, hormone, infection, and arthritis.
Contact
43, Geodudanji 1-gil
Dongnae-myeon
Gang-won-do
Chuncheon-si200-883
KORT: +82 332431400
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
532
Stocks News & Analysis
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
stocks
Our three most overvalued ASX shares
These three companies are trading at a significant premium to our fair value.
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,070.80 | 49.70 | -0.54% |
| CAC 40 | 7,734.84 | 60.06 | 0.78% |
| DAX 40 | 23,807.13 | 210.15 | 0.89% |
| Dow JONES (US) | 45,514.95 | 114.09 | 0.25% |
| FTSE 100 | 9,221.44 | 13.23 | 0.14% |
| HKSE | 25,830.53 | 196.62 | 0.77% |
| NASDAQ | 21,798.70 | 98.31 | 0.45% |
| Nikkei 225 | 43,656.54 | 12.73 | 0.03% |
| NZX 50 Index | 13,227.90 | 53.24 | -0.40% |
| S&P 500 | 6,495.15 | 13.65 | 0.21% |
| S&P/ASX 200 | 8,792.70 | 48.20 | -0.55% |
| SSE Composite Index | 3,815.61 | 11.24 | -0.29% |